Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Hotel Ilunion Alcora Sevilla

Sep 27, 2022 8:30 AM - Sep 28, 2022 3:00 PM

San Juan de Aznalfarache, 41920 Sevilla, Spain

Accelerating CMC Workshop

This Workshop will focus on the currently most relevant topics in the CMC (Chemistry, Manufacturing and Controls) regulatory space with a global perspective.

Session 3: The future of CMC Submissions: Digital Data Dossier

Session Chair(s)

Ben  Thompson

Ben Thompson

Vice President, CMC and Non-clinical Regulatory Affairs, GlaxoSmithKline, United Kingdom

Henrik K.  Nielsen, PhD, MBA, MSc

Henrik K. Nielsen, PhD, MBA, MSc

Director, HKN Solutions, Denmark

The future of CMC Submissions: Digital Data Dossier

Speaker(s)

Lawrence  Yu, PhD

FDA’s New Quality Initiative: Knowledge-aided Assessment and Structured Application (KASA)

Lawrence Yu, PhD

Director, Office of New Drug Products, OPQ, CDER, FDA , United States

Henrik K.  Nielsen, PhD, MBA, MSc

Update on ICH M4Q Progress and Industry Perspective

Henrik K. Nielsen, PhD, MBA, MSc

Director, HKN Solutions, Denmark

Rita  Algorri, PhD, MS

Modernizing CMC Data Exchange: A Cloud-Based Approach to Structured Data and Content Management

Rita Algorri, PhD, MS

Associate Director, Global Regulatory Affairs, Amgen, United States

Rodrigo  Palacios, MBA

Modernizing CMC Data Exchange: A Cloud-Based Approach to Structured Data and Content Management

Rodrigo Palacios, MBA

Senior Director, Regulatory Policy, F. Hoffman - La Roche Ltd., Switzerland

Danny  Verkooij

Change Assessment Knowledge Engine (CAKE): Accelerating Regulatory CMC Assessments of Proposed Changes

Danny Verkooij

Associate Principal Scientist, Site CMC, Merck Sharp & Dohme, Netherlands

Amy  Keegan

Change Assessment Knowledge Engine (CAKE): Accelerating Regulatory CMC Assessments of Proposed Changes

Amy Keegan

, MSD, United States

Matt  Popkin, PhD

ICMRA-ICH-PIC/S-IPRP Joint Reflection Paper on PQ KMS Capability

Matt Popkin, PhD

Senior Director, CMC Excellence, Global Regulatory Affairs, GSK, United Kingdom

Saeed  Al Awadh

Panel discussion with Q&A

Saeed Al Awadh

Expert, Saudi Food and Drug Authority, Saudi Arabia

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.